Please Wait...

Key Cardiovascular Mergers and Acquisitions

With over 25 years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in providing comprehensive services with unrivalled scientific and technical leadership.  Over the last decade, Bioclinica has grown organically and through strategic acquisitions to enhance and strengthen its cardiac safety expertise, resources and offerings for clinical trial sponsors.

In 2004, Bioclinica (formerly Bio-Imaging Technologies) acquired Heartcore BV, a global provider of centralized cardiovascular imaging analysis specializing in various quantitative image analysis services. In 2013, Bioclinica merged with Core Lab Partners, adding renowned scientific expertise from Medifacts to its cardiovascular team, bolstering its centralized cardiovascular services portfolio and expanding its presence in Asia.  Most recently, in 2014, Bioclinica merged with SYNARC, supplementing an already strong cardiac safety program with additional scientific expertise and operations in the area of Echocardiography and cardiovascular imaging.

Bioclinica continues to strengthen its cardiovascular offerings, providing sponsors with world-class expertise, operations and technology to design, manage, and analyze cardiac safety data in support of new treatments.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

We're hiring recent tech grads in #RTP for #pharma sector! Our innov. clinical financial solution gives our client… https://t.co/GHgOfszO0T
bioclinica (11 hours ago)
Great to be @DrugInfoAssn DIA China! Ask us @bioclinica how sponsors & CROs can optimize electronic data capture… https://t.co/TtE4AiLnqY
bioclinica (17 hours ago)
RT @bioclinica: Kinks in the clinical supply chain? Check out how one of our clients is using clinical supply optimization technology for m…
bioclinica (17 hours ago)
RT @bioclinica: Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (17 hours ago)
Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (Yesterday)
Case processing is an important aspect of post-marketing drug safety surveillance. Here's a case study showing how… https://t.co/UMYp92Puvc
bioclinica (2 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen